Cover Image

Effect of denosumab on bone mineral density in Japanese women with osteopenia treated with aromatase inhibitors for breast cancer: subgroup analyses of a Phase II study

Katsuhiko Nakatsukasa,1 Hiroshi Koyama,2 Yoshimi Ouchi,1 Kouichi Sakaguchi,1 Yoshifumi Fujita,1 Takayuki Matsuda,3 Makoto Kato,4 Eiichi Konishi,5 Tetsuya Taguchi1 1Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; 2Department of Breast Surgery, Nara...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nakatsukasa K (Author), Koyama H (Author), Ouchi Y (Author), Sakaguchi K (Author), Fujita Y (Author), Matsuda T (Author), Kato M (Author), Konishi E (Author), Taguchi T (Author)
Format:	Book
Published:	Dove Medical Press, 2018-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
by: Nakamura Y, et al.
Published: (2018)

Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
by: Kamimura M, et al.
Published: (2018)

Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment
by: Nakamura Y, et al.
Published: (2017)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018)

Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study
by: Yusuke Kunimoto, et al.
Published: (2023)

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
by: Yi Chen, et al.
Published: (2021)

Indices in dental image exams for bone mineral density evaluation of aromatase inhibitor users
by: Sâmila Gonçalves Barra, et al.
Published: (2022)

Assessment of the Relationship Between Bone Mineral Density and Disease Activity in Ankylosing Spondylitis Patients with Osteopenia
by: Hayal Güler, et al.
Published: (2013)

Relationship between Two Panoramic Radiography Indices and Bone Mineral Density of Postmenopausal Women with Osteopenia and Osteoporosis
by: Nader Navabi, et al.
Published: (2018)

Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study
by: Mona Alshahawey, et al.
Published: (2024)

Frequency of Osteoporosis and Osteopenia According To Bone Mineral Density of Proximal Femur Subregions in Normal and Osteopenic Postmenopausal Women With Respect to Total Hip Bone
by: Murat Ersöz, et al.
Published: (2002)

Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis
by: Uehara M, et al.
Published: (2018)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
by: Iwamoto J, et al.
Published: (2022)

Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study
by: Nadine Heimgartner, et al.
Published: (2020)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
by: Iwamoto J, et al.
Published: (2018)

Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa
by: Nakamura Y, et al.
Published: (2018)

THE ROLE OF AROMATASE IN THE DEVELOPMENT OF ENDOMETRIOSIS
by: L. V. Adamyan, et al.
Published: (2017)

Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab
by: Claudia Kobel, et al.
Published: (2019)

OSTEOPENIA IN CHILDHOOD AND ADOLESCENCE
by: Georgiana Russu, et al.
Published: (2014)

Mandibular bone mineral density in patients with Behçet’s disease
by: Asutay F, et al.
Published: (2015)

Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report
by: Uehara M, et al.
Published: (2019)

High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
by: Ishikawa K, et al.
Published: (2016)

Anticonvulsants and Bone Mineral Density
by: J Gordon Millichap
Published: (1995)

OSTEOPENIA IN CHILDREN WITH MALABSORPTION SYNDROM
by: Tania Elena Rusu, et al.
Published: (2016)

The Ability of Cone Beam Computed Tomography to Predict Osteopenia and Osteoporosis via Radiographic Density Derived from Cervical Vertebrae
by: Salar Payahoo, et al.
Published: (2019)

Association Between Low Bone Mineral Density Risk Factors and Estrogen Receptor ? Gene Polymorphisms in Japanese Female Athletes
by: Tetsuro Kobayashi, et al.
Published: (2021)

Efficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case report
by: Uehara M, et al.
Published: (2018)

Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients
by: Marco Bonani, et al.
Published: (2016)

Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
by: Jun Iwamoto, et al.
Published: (2009)

Baseline Body Composition and Physical Activity Level Recommended for Optimal Bone Mineral Density in Young Women
by: Sangun Lee, et al.
Published: (2022)

Correction to: Efficacy of radiographic density values of the first and second cervical vertebrae recorded by CBCT technique to identify patients with osteoporosis and osteopenia
by: Farzad Esmaeili, et al.
Published: (2018)

Physical activity and bone mineral density
by: Međedović Bojan, et al.
Published: (2015)

Bone Mineral Density Unaffected by Antiepileptics
by: J Gordon Millichap
Published: (1998)

Assessment of Bone Mineral Density in Osteoporosis
by: Dilşad Sindel, et al.
Published: (2015)

Bone Mineral Density in Ankylosing Spondylitis
by: Bahar Çakmak, et al.
Published: (2003)

Bone Mineral Density in Stroke Patients
by: Nilüfer Balcı, et al.
Published: (2005)

Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)‐ketamine, but not (S)‐ketamine
by: Yuko Fujita, et al.
Published: (2020)

Aromatase inhibitors in post-menopausal endometriosis
by: Devroey Paul, et al.
Published: (2011)

Aromatase inhibitors in stimulated IVF cycles
by: Tournaye Herman, et al.
Published: (2011)